NCT04472364View on ClinicalTrials.gov

HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

April 8, 2024

Study Completion Date

April 8, 2024

Conditions
Upper Gastrointestinal Bleeding
Interventions
DEVICE

HemoPill Acute ®

Capsule positive: Endoscopy endoscopy will be performed within 12 hours. Capsule negative: Endoscopy will be performed after 48 to 96 hours.

Trial Locations (4)

10249

Klinikum Friedrichshain, Berlin

63069

Sana Klinikum Offenbach GmbH, Offenbach

79106

Universitästklinik Freiburg, Freiburg im Breisgau

97080

Universitätsklinik Würzburg, Würzburg

All Listed Sponsors
collaborator

Vivantes Netzwerk für Gesundheit GmbH

OTHER

collaborator

University Hospital Freiburg

OTHER

collaborator

Sana Klinikum Offenbach

OTHER

lead

Wuerzburg University Hospital

OTHER

NCT04472364 - HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding | Biotech Hunter | Biotech Hunter